News

Enter your email address to get Core One Labs News Alerts.

News

Enter your email address to get Core One Labs News Alerts.
Company News
April 21, 2023
Core One’s Awakened Completes Successful Synthetic Production of Psilocin in its GMP Certified Manufacturing Facility
Vancouver, British Columbia, Canada – April 21, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
April 04, 2023
Core One Labs Applauds Study Linking Psychedelic Treatment to Substantial Reduction in Alcohol Misuse & PTSD Symptoms in US Special Operations Forces Veterans
Vancouver, British Columbia, Canada – April 4, 2023 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more
Company News
January 24, 2023
Core One Labs’ Akome Signs Contract with University of Barcelona: Initiating Animal Model Studies on Psychedelics Drug Development to Combat a Variety of Neurological Diseases
Vancouver, British Columbia, Canada – January 24, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more
Company News
January 13, 2023
Core One Labs’ Acquires GMP Drug Inc.: Positioning Itself as a Full Cycle Psychedelics Supply Chain Solution for Clinicians, Researchers and other Drug Developers
Vancouver, British Columbia, Canada – January 13, 2023 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6, WKN: A3CSSU)...
Read more
Company News
December 13, 2022
Core One Labs’ Subsidiary Vocan Biotechnologies Achieves Development Milestones
Vancouver, British Columbia, Canada – December 13, 2022 – Core One Labs Inc. (CSE: COOL), (OTCQB: CLABF), (Frankfurt: LD6,...
Read more
Company News
November 25, 2022
CORE ONE LABS’ ANNOUNCES APPOINTMENT OF BF BORGERS CPA PC AS ITS NEW AUDITOR
Vancouver, British Columbia, Canada – November 25, 2022 – Core One Labs Inc. (CSE: COOL), (OTC: CLABF), (Frankfurt: LD6,...
Read more